Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells.

MLA

Pennisi, Martina, et al. “Modified EASIX Predicts Severe Cytokine Release Syndrome and Neurotoxicity after Chimeric Antigen Receptor T Cells.” Blood Advances, vol. 5, no. 17, Sept. 2021, pp. 3397–406. EBSCOhost, https://doi.org/10.1182/bloodadvances.2020003885.

APA

Pennisi, M., Sanchez-Escamilla, M., Flynn, J. R., Shouval, R., Alarcon Tomas, A., Silverberg, M. L., Batlevi, C., Brentjens, R. J., Dahi, P. B., Devlin, S. M., Diamonte, C., Giralt, S., Halton, E. F., Jain, T., Maloy, M., Mead, E., Palomba, M. L., Ruiz, J., Santomasso, B., … Perales, M.-A. (2021). Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood Advances, 5(17), 3397–3406. https://doi.org/10.1182/bloodadvances.2020003885

Chicago

Pennisi, Martina, Miriam Sanchez-Escamilla, Jessica R Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynn Silverberg, Connie Batlevi, et al. 2021. “Modified EASIX Predicts Severe Cytokine Release Syndrome and Neurotoxicity after Chimeric Antigen Receptor T Cells.” Blood Advances 5 (17): 3397–3406. doi:10.1182/bloodadvances.2020003885.